Media personality Jim Cramer often makes bold statements about companies and a lot of times, he proves himself correct.

In this piece, we will look at the stocks Jim Cramer recently discussed.

Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...

Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...